Development of cardiovascular drugs: The U.S. regulatory milieu from the perspective of a participating nonregulator
Jeffrey S. BorerVolume:
44
Year:
2004
Language:
english
DOI:
10.1016/j.jacc.2004.07.059
File:
PDF, 98 KB
english, 2004